Literature DB >> 12407077

Probing an open CFTR pore with organic anion blockers.

Zhen Zhou1, Shenghui Hu, Tzyh-Chang Hwang.   

Abstract

The cystic fibrosis transmembrane conductance regulator (CFTR) is an ion channel that conducts Cl- current. We explored the CFTR pore by studying voltage-dependent blockade of the channel by two organic anions: glibenclamide and isethionate. To simplify the kinetic analysis, a CFTR mutant, K1250A-CFTR, was used because this mutant channel, once opened, can remain open for minutes. Dose-response relationships of both blockers follow a simple Michaelis-Menten function with K(d) values that differ by three orders of magnitude. Glibenclamide blocks CFTR from the intracellular side of the membrane with slow kinetics. Both the on and off rates of glibenclamide block are voltage dependent. Removing external Cl- increases affinity of glibenclamide due to a decrease of the off rate and an increase of the on rate, suggesting the presence of a Cl- binding site external to the glibenclamide binding site. Isethionate blocks the channel from the cytoplasmic side with fast kinetics, but has no measurable effect when applied extracellularly. Increasing the internal Cl- concentration reduces isethionate block without affecting its voltage dependence, suggesting that Cl- and isethionate compete for a binding site in the pore. The voltage dependence and external Cl- concentration dependence of isethionate block are nearly identical to those of glibenclamide block, suggesting that these two blockers may bind to a common binding site, an idea further supported by kinetic studies of blocking with glibenclamide/isethionate mixtures. By comparing the physical and chemical natures of these two blockers, we propose that CFTR channel has an asymmetric pore with a wide internal entrance and a deeply embedded blocker binding site where local charges as well as hydrophobic components determine the affinity of the blockers.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12407077      PMCID: PMC2229557          DOI: 10.1085/jgp.20028685

Source DB:  PubMed          Journal:  J Gen Physiol        ISSN: 0022-1295            Impact factor:   4.086


  37 in total

1.  Point mutations in the pore region directly or indirectly affect glibenclamide block of the CFTR chloride channel.

Authors:  Jyoti Gupta; Paul Linsdell
Journal:  Pflugers Arch       Date:  2001-12-08       Impact factor: 3.657

2.  Potassium channel receptor site for the inactivation gate and quaternary amine inhibitors.

Authors:  M Zhou; J H Morais-Cabral; S Mann; R MacKinnon
Journal:  Nature       Date:  2001-06-07       Impact factor: 49.962

3.  Voltage-dependent flickery block of an open cystic fibrosis transmembrane conductance regulator (CFTR) channel pore.

Authors:  Z Zhou; S Hu; T C Hwang
Journal:  J Physiol       Date:  2001-04-15       Impact factor: 5.182

4.  Thiocyanate as a probe of the cystic fibrosis transmembrane conductance regulator chloride channel pore.

Authors:  P Linsdell
Journal:  Can J Physiol Pharmacol       Date:  2001-07       Impact factor: 2.273

5.  Cystic fibrosis transmembrane conductance regulator. Physical basis for lyotropic anion selectivity patterns.

Authors:  S S Smith; E D Steinle; M E Meyerhoff; D C Dawson
Journal:  J Gen Physiol       Date:  1999-12       Impact factor: 4.086

6.  Gating of cystic fibrosis transmembrane conductance regulator chloride channels by adenosine triphosphate hydrolysis. Quantitative analysis of a cyclic gating scheme.

Authors:  S Zeltwanger; F Wang; G T Wang; K D Gillis; T C Hwang
Journal:  J Gen Physiol       Date:  1999-04       Impact factor: 4.086

7.  Multiple inhibitory effects of Au(CN)(2-) ions on cystic fibrosis transmembrane conductance regulator Cl(-) channel currents.

Authors:  Paul Linsdell; Xiandi Gong
Journal:  J Physiol       Date:  2002-04-01       Impact factor: 5.182

8.  CFTR: covalent and noncovalent modification suggests a role for fixed charges in anion conduction.

Authors:  S S Smith; X Liu; Z R Zhang; F Sun; T E Kriewall; N A McCarty; D C Dawson
Journal:  J Gen Physiol       Date:  2001-10       Impact factor: 4.086

9.  Novel pore-lining residues in CFTR that govern permeation and open-channel block.

Authors:  S McDonough; N Davidson; H A Lester; N A McCarty
Journal:  Neuron       Date:  1994-09       Impact factor: 17.173

10.  The barium site in a potassium channel by x-ray crystallography.

Authors:  Y Jiang; R MacKinnon
Journal:  J Gen Physiol       Date:  2000-03       Impact factor: 4.086

View more
  31 in total

1.  Differential contribution of TM6 and TM12 to the pore of CFTR identified by three sulfonylurea-based blockers.

Authors:  Guiying Cui; Binlin Song; Hussein W Turki; Nael A McCarty
Journal:  Pflugers Arch       Date:  2011-12-13       Impact factor: 3.657

2.  Differential expression of Kir6.1 and SUR2B mRNAs in the vasculature of various tissues in rats.

Authors:  L Li; J Wu; C Jiang
Journal:  J Membr Biol       Date:  2003-11-01       Impact factor: 1.843

3.  Time-dependent interactions of glibenclamide with CFTR: kinetically complex block of macroscopic currents.

Authors:  Z-R Zhang; G Cui; S Zeltwanger; N A McCarty
Journal:  J Membr Biol       Date:  2004-10-01       Impact factor: 1.843

4.  Interactions between impermeant blocking ions in the cystic fibrosis transmembrane conductance regulator chloride channel pore: evidence for anion-induced conformational changes.

Authors:  Ning Ge; Paul Linsdell
Journal:  J Membr Biol       Date:  2006-06-22       Impact factor: 1.843

Review 5.  CFTR pharmacology.

Authors:  Olga Zegarra-Moran; Luis J V Galietta
Journal:  Cell Mol Life Sci       Date:  2016-10-04       Impact factor: 9.261

6.  Divergent CFTR orthologs respond differently to the channel inhibitors CFTRinh-172, glibenclamide, and GlyH-101.

Authors:  Maximilian Stahl; Klaus Stahl; Marie B Brubacher; John N Forrest
Journal:  Am J Physiol Cell Physiol       Date:  2011-09-21       Impact factor: 4.249

7.  Loop diuretics are open-channel blockers of the cystic fibrosis transmembrane conductance regulator with distinct kinetics.

Authors:  Min Ju; Toby S Scott-Ward; Jia Liu; Pissared Khuituan; Hongyu Li; Zhiwei Cai; Stephen M Husbands; David N Sheppard
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

Review 8.  Cystic fibrosis transmembrane conductance regulator chloride channel blockers: Pharmacological, biophysical and physiological relevance.

Authors:  Paul Linsdell
Journal:  World J Biol Chem       Date:  2014-02-26

9.  Direct sensing of intracellular pH by the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel.

Authors:  Jeng-Haur Chen; Zhiwei Cai; David N Sheppard
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

10.  On the mechanism of CFTR inhibition by a thiazolidinone derivative.

Authors:  Zoia Kopeikin; Yoshiro Sohma; Min Li; Tzyh-Chang Hwang
Journal:  J Gen Physiol       Date:  2010-11-15       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.